As research becomes ever more sophisticated and regulatory requirements tighten, ProPure ™ is a game-changer for life science ...

The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.

An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...

The "atopic march" describes the age-related progression of allergic diseases, presenting as the sequential onset of atopic ...

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...

Vishal Mukund Sonje, Vaccine Manufacturing Lead, CEPI, talks about the challenges that arise in the manufacturing of vaccines ...

Inflammatory bowel diseases (IBDs), such as Crohn's disease and ulcerative colitis, are chronic and autoimmune conditions ...

Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 studyEfdoralprin alfa ...

While vaccine hesitancy is a global phenomenon, in Pakistan it was aggravated by the CIA’s use of a fake hepatitis B ...